Verastem, Inc. (VSTM)
8.15
-0.29
(-3.44%)
USD |
NASDAQ |
Nov 13, 10:31
Verastem Net Income (Annual) : -209.47M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -209.47M |
| December 31, 2024 | -130.64M |
| December 31, 2023 | -87.37M |
| December 31, 2022 | -73.81M |
| December 31, 2021 | -71.20M |
| December 31, 2020 | -67.73M |
| December 31, 2019 | -149.21M |
| December 31, 2018 | -72.43M |
| Date | Value |
|---|---|
| December 31, 2017 | -67.80M |
| December 31, 2016 | -36.44M |
| December 31, 2015 | -57.86M |
| December 31, 2014 | -53.36M |
| December 31, 2013 | -41.20M |
| December 31, 2012 | -31.99M |
| December 31, 2011 | -13.72M |
| December 31, 2010 | -0.786M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Cytokinetics, Inc. | -784.96M |
| Inovio Pharmaceuticals, Inc. | -84.95M |
| Rigel Pharmaceuticals, Inc. | 367.02M |
| United Therapeutics Corp. | 1.335B |
| SELLAS Life Sciences Group, Inc. | -26.86M |